general Archived signal Translated · English · 2–5m lag

The league group KiOmed Pharma opens the market for aesthetic medicine

The KitoZyme pharmaceutical group branch, piloted by François Blondel, offers a second growth pill after which it is dedicated to the treatment of gene arthrosis. ...

Reported by La Libre Belgique
Read the complete report at La Libre Belgique
Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

2 reports · 2 sources

La Libre BelgiqueThe league group KiOmed Pharma opens the market for aesthetic medicineLa Libre BelgiqueThe league group KiOmed Pharma opens the market for aesthetic medicine
INCIDENT EVOLUTION

10 recorded states

Signal first indexedP1 · 68% quality · 1 source

Corroboration 1→2 sources · quality 68→72P1 · 72% quality · 2 sources

Quality 72→76P1 · 76% quality · 2 sources

Quality 76→80P1 · 80% quality · 2 sources

Quality 80→84P1 · 84% quality · 2 sources

Quality 84→88P1 · 88% quality · 2 sources

Quality 88→92P1 · 92% quality · 2 sources

Quality 92→96P1 · 96% quality · 2 sources

Quality 96→99P1 · 99% quality · 2 sources

Headline updatedP1 · 99% quality · 2 sources

Explore this day in the archive →
QUALITY CONTROL

Report this signal

Reports are anonymous and retained privately for editorial review.